We are live on ! Find out more
IBBQ icon

Invesco NASDAQ Biotechnology ETF

15 hedge funds and large institutions have $9.26M invested in Invesco NASDAQ Biotechnology ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

3.35% less ownership

Funds ownership: 37.02%33.68% (-3.3%)

12% less funds holding

Funds holding: 1715 (-2)

15% less capital invested

Capital invested by funds: $10.9M → $9.26M (-$1.65M)

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

IBBQ Hedge Fund Activity: Q2 2024 in Review

15 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q2 2024, worth a combined $9.26M — down 15% from $10.9M a quarter earlier.

Fund positioning in IBBQ was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 6 added to existing stakes and 2 trimmed.

The largest buyer was Strategic Financial Concepts, opening a new position worth an estimated $1.94M. The largest seller was Lake Street Advisors Group, exiting entirely with an estimated $286K sold.

  • 15 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q2 2024, down from 17 in Q1 2024.
  • Funds reported $9.26M of Invesco NASDAQ Biotechnology ETF stock for Q2 2024, down 15% quarter-over-quarter.
  • 1 fund opened new Invesco NASDAQ Biotechnology ETF positions in Q2 2024 and 1 closed out, a net change of 0 holders.
  • The largest Invesco NASDAQ Biotechnology ETF buyer in Q2 2024 was Strategic Financial Concepts, an estimated $1.94M added.
  • The largest Invesco NASDAQ Biotechnology ETF seller in Q2 2024 was Lake Street Advisors Group, an estimated $286K sold.

Based on aggregated 13F filings for Q2 2024.